Related references
Note: Only part of the references are listed.In Vitro and In Vivo Preclinical Effects of Type I IFNs on Gliomas
Vasiliki Galani et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2017)
CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010-2014
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2017)
Systemic AAV9-IFNβ gene delivery treats highly invasive glioblastoma
Dwijit GuhaSarkar et al.
NEURO-ONCOLOGY (2016)
Interferon-β and temozolomide combination therapy for temozolomide monotherapy-refractory malignant gliomas
Hiroshi Kawaji et al.
MOLECULAR AND CLINICAL ONCOLOGY (2015)
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
Mark R. Gilbert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Bevacizumab for Newly Diagnosed Glioblastoma Reply
Olivier L. Chinot et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Bevacizumab plus Radiotherapy-Temozolomide for Newly Diagnosed Glioblastoma
Olivier L. Chinot et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Benefits of Interferon-β and Temozolomide Combination Therapy for Newly Diagnosed Primary Glioblastoma With the Unmethylated MGMT Promoter A Multicenter Study
Kazuya Motomura et al.
CANCER (2011)
A multicenter phase I trial of combination therapy with interferon-β and temozolomide for high-grade gliomas (INTEGRA study): the final report
Toshihiko Wakabayashi et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp et al.
LANCET ONCOLOGY (2009)
A multicenter phase I trial of Interferon-β and Temozolomide Combination therapy for high-grade gliomas (INTEGRA Study)
Toshihiko Wakabayashi et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2008)
A combination of IFN-β and temozolomide in human glioma xenograft models:: implication of p53-mediated MGMT downregulation
Atsushi Natsume et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2008)
Phase II Radiation Therapy Oncology Group trial of conventional radiation therapy followed by treatment with recombinant interferon-β for supratentorial glioblastoma:: Results of RTOG 9710
Howard Colman et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
IFN-β down-regulates the expression of DNA repair gene MGMT and sensitizes resistant glioma cells to temozolomide
A Natsume et al.
CANCER RESEARCH (2005)
MGMT gene silencing and benefit from temozolomide in glioblastoma
ME Hegi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Human interferon beta, nimustine hydrochloride, and radiation therapy in the treatment of newly diagnosed malignant astrocytomas
T Watanabe et al.
JOURNAL OF NEURO-ONCOLOGY (2005)
Apoptosis and interferons: Role of interferon-stimulated genes as mediators of apoptosis
M Chawla-Sarkar et al.
APOPTOSIS (2003)
Initial and maintenance combination treatment with interferon-β, MCNU (Ranimustine), and radiotherapy for patients with previously untreated malignant glioma
T Wakabayashi et al.
JOURNAL OF NEURO-ONCOLOGY (2000)
Efficacy of post operative adjuvant therapy with human interferon beta, MCNU and radiation (IMR) for malignant glioma: Comparison among three protocols
N Hatano et al.
ACTA NEUROCHIRURGICA (2000)
Share Paper
